A safety clinical trial shows a possible increased risk of cancer with the weight-loss drug belviq, belviq xr consider the benefits and risks when deciding to prescribe or continue patients on. Belviq and cancer. Topic: risk factors tags: prescription medications the weight management medicine belviq (chemical name: lorcaserin), also available as belviq xr, seems to be linked to an increase in cancer risk, according to an announcement on jan 14, 2020, by the us food and drug administration (fda).
belviq and cancer
There was a range of cancers, with pancreatic, colorectal and lung cancer reported more often in the patients who took belviq, the fda said the agency said no special cancer screening is needed. Weight loss drug belviq might cause cancer, fda warns. by kate gibson january 15, 2020 / 1:52 pm / moneywatch federal regulators are warning the public of a possible increased risk of cancer in. Fda recalls lorcaserin (belviq) due to its potential cancer risk; obesity is a chronic health condition that affects more than one in three americans. some individuals struggling with weight.
Comments
Post a Comment